BioLineRx Ltd. (BLRX) Operating income 2016–2025
BioLineRx Ltd. (BLRX) annual operating income history from SEC filings — each fiscal year as reported.
-$10.3MFY2025 · since FY2016: -$16.5M → -$10.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$10.3M | +49.6% |
| FY2024 | -$20.4M | +58.9% |
| FY2023 | -$49.7M | -70.4% |
| FY2022 | -$29.2M | -17.7% |
| FY2021 | -$24.8M | -8.1% |
| FY2020 | -$22.9M | +18.4% |
| FY2019 | -$28.1M | -9.8% |
| FY2018 | -$25.6M | -1.4% |
| FY2017 | -$25.2M | -52.8% |
| FY2016 | -$16.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice